Results 81 to 90 of about 2,723 (121)

Familial Hypercholesterolemia in Women: Diagnosis, Treatment, and Cardiovascular Outcomes Across the Lifespan. [PDF]

Curr Atheroscler Rep
Karungi I, Holven KB, Ray KK, Elshorbagy A.   +3 more
europepmc   +1 more source

Are lipid-lowering drugs harmful to cognitive performance?: A Mendelian randomization study. [PDF]

Medicine (Baltimore)
Han L, Su C, Lian R, Han J, Fan X, Gao L.   +5 more
europepmc   +1 more source

Low HDL-The Challenge. [PDF]

Clin Med Res
Rezkalla SH, Kloner RA.
europepmc   +1 more source

Real-world effectiveness and cardiovascular outcomes of PCSK9 inhibitor therapy: a prospective registry study. [PDF]

Lipids Health Dis
Kafol J, Fras Z, Novakovic M, Sperling LS, Cevc M, Krevel B, Kafol L, Kelenc A, Kepic K, Vrbinc K, Svarc M, Groselj U, Jug B.   +12 more
europepmc   +1 more source

A disproportionality analysis on proprotein convertase subtilisin/kexin type 9 inhibitors and hypersensitivity and anaphylaxis. [PDF]

Sci Rep
Dermiki-Gkana F, Gravel CA, Kontogiorgis C, Douros A.   +3 more
europepmc   +1 more source

Exploring the Other Side of Medication: A Patient Interview Study on Anti-PCSK9 Monoclonal Antibodies. [PDF]

Cardiovasc Ther
Zhang T, Li D, Ning Y, Shi J, Hu Y.
europepmc   +1 more source

Impact of Age on Lipid-Lowering Therapy Prescriptions and LDL-Cholesterol Control: Insights from the PORTRAIT-DYS Study. [PDF]

Glob Heart
Gavina C, Seabra D, Oliveira S, Teixeira C, Ruivo JA, Lourenço-Silva N, Luz AR, Jácome C, Araújo F.   +8 more
europepmc   +1 more source

SVO70 (Optimal Target Low-Density Lipoprotein Cholesterol Level for Small Vessel Occlusion Stroke): Rationale and Study Design. [PDF]

J Am Heart Assoc
Yang W, Song TJ, Koh SH, Jeong HS, Sohn SI, Kim YS, Kim BJ, Jung JM, Jung KH, Kim JM, Jang H, Lee EJ, Chung M, Kim S, Park HK, Yu S, Cho YJ, Kim JT, Kim Y, Kim C, Kim HY, Oh MS, Kim DH, Lee YB, Eun MY, Park HY, Kang K, Kwon HM, Cho HJ, Kim JG, Choi JC, Yoo J, Nam HS, Ok T, Cho AH, Lee JY, Shin JY, Park JH, Park KY, Shin DI, Do Y, Chang Y, Jung S, Jung YH, Seo WK, Jeong SW, Ha SY, An SJ, Ahn SH, Hwang YH, Lee SH.   +50 more
europepmc   +1 more source

Attainment of low-density lipoprotein cholesterol goals in patients undergoing coronary revascularization in the contemporary clinical practice. [PDF]

Indian Heart J
Bansal M, Kasliwal RR, Chandra P, Kapoor R, Chouhan N, Bhan A, Trehan N.   +6 more
europepmc   +1 more source

Obicetrapib and ezetimibe enhance LDL receptor-mediated VLDL clearance and regress atherosclerosis on atorvastatin background. [PDF]

J Lipid Res
Inia JA, Zhang LH, Keijzer N, Worms N, van Nieuwkoop-van Straalen A, Ditmarsch M, de Kleer M, Jukema JW, Kastelein JJP, Szarek M, van den Hoek AM, Stokman G, Pieterman EJ, Princen HMG.   +13 more
europepmc   +1 more source